Agilent Technologies (NYSE:A) Releases FY 2022 Earnings Guidance – MarketBeat

Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Agilent Technologies (NYSE:A – Get Rating) issued an update on its FY 2022 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $5.06-$5.08 for the period, compared to the consensus estimate of $4.76. The company issued revenue guidance of $6.75 billion-$6.78 billion, compared to the consensus revenue estimate of $6.51 billion. Agilent Technologies also updated its Q4 2022 guidance to $1.38-$1.40 EPS.

Agilent Technologies Trading Down 2.7 %

Agilent Technologies stock opened at $133.94 on Tuesday. The firm has a 50 day moving average of $124.63 and a 200 day moving average of $127.40. The firm has a market capitalization of $40.01 billion, a price-to-earnings ratio of 30.51, a P/E/G ratio of 2.71 and a beta of 1.06. Agilent Technologies has a 12-month low of $112.52 and a 12-month high of $179.57. The company has a current ratio of 1.94, a quick ratio of 1.41 and a debt-to-equity ratio of 0.54.
Agilent Technologies (NYSE:A – Get Rating) last announced its quarterly earnings data on Tuesday, August 16th. The medical research company reported $1.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.20 by $0.14. The business had revenue of $1.72 billion during the quarter, compared to analyst estimates of $1.64 billion. Agilent Technologies had a net margin of 19.94% and a return on equity of 28.46%. The company’s revenue was up 8.3% on a year-over-year basis. During the same period last year, the firm posted $1.10 EPS. As a group, research analysts predict that Agilent Technologies will post 5.07 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on A shares. Robert W. Baird lifted their target price on Agilent Technologies from $155.00 to $160.00 and gave the company an outperform rating in a research note on Wednesday, August 17th. Evercore ISI lifted their target price on Agilent Technologies to $145.00 in a research note on Monday. KeyCorp cut their target price on Agilent Technologies from $195.00 to $155.00 and set an overweight rating on the stock in a research note on Thursday, June 2nd. UBS Group initiated coverage on Agilent Technologies in a report on Wednesday, July 20th. They issued a buy rating and a $139.00 price target for the company. Finally, Bank of America raised their price target on Agilent Technologies from $148.00 to $155.00 and gave the stock a buy rating in a report on Wednesday, August 17th. Four research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of Moderate Buy and an average target price of $150.17.

Insider Buying and Selling

In related news, VP Jacob Thaysen sold 5,879 shares of the business’s stock in a transaction that occurred on Thursday, June 2nd. The stock was sold at an average price of $127.43, for a total transaction of $749,160.97. Following the completion of the sale, the vice president now directly owns 88,737 shares in the company, valued at $11,307,755.91. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, VP Padraig Mcdonnell sold 1,000 shares of the stock in a transaction dated Thursday, June 30th. The stock was sold at an average price of $118.62, for a total transaction of $118,620.00. Following the transaction, the vice president now owns 17,826 shares of the company’s stock, valued at approximately $2,114,520.12. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, VP Jacob Thaysen sold 5,879 shares of the company’s stock in a transaction dated Thursday, June 2nd. The stock was sold at an average price of $127.43, for a total value of $749,160.97. Following the sale, the vice president now owns 88,737 shares in the company, valued at approximately $11,307,755.91. The disclosure for this sale can be found here.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the business. Penserra Capital Management LLC acquired a new stake in Agilent Technologies during the 1st quarter worth approximately $60,000. Brown Brothers Harriman & Co. raised its holdings in Agilent Technologies by 169.5% during the first quarter. Brown Brothers Harriman & Co. now owns 1,237 shares of the medical research company’s stock worth $164,000 after purchasing an additional 778 shares during the last quarter. Covestor Ltd raised its holdings in Agilent Technologies by 171.0% during the first quarter. Covestor Ltd now owns 1,241 shares of the medical research company’s stock worth $164,000 after purchasing an additional 783 shares during the last quarter. Geller Advisors LLC increased its position in Agilent Technologies by 18.5% during the first quarter. Geller Advisors LLC now owns 1,602 shares of the medical research company’s stock worth $212,000 after buying an additional 250 shares in the last quarter. Finally, Prelude Capital Management LLC purchased a new position in Agilent Technologies during the first quarter worth $223,000.

About Agilent Technologies

(Get Rating)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Further Reading

• Get a free copy of the StockNews.com research report on Agilent Technologies (A)
• MarketBeat Podcast: Fantasy Football Strategy With Your Stock Portfolio
• Should You Buy These Copper Stocks Ahead Of Monster Demand?
• Three Industrial Stocks That Can Weather a Stormy Recession
• Bed Bath & Beyond Meat: Is BYND the Next Big Short Squeeze?
• Denbury Rises On Rumor Of A Sale, But Lags Other Energy Names

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Agilent Technologies, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Agilent Technologies wasn’t on the list.
While Agilent Technologies currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Complete the form below to receive the latest headlines and analysts’ recommendations for your stocks with our free daily email newsletter:
Strategy for maintaining your portfolio value while still making withdrawals to pay your life expenses. And most importantly, avoiding big losses.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
As Featured By:
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice YouTube

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer.

source